Despite these limitations, EL219 shows promise as a novel, broad-spectrum polyene with superior activity to LAMB, particularly against resistant Aspergillus species, warranting further investigations and eventually translating into clinical trial testing against IPA. The gene discussed is GRAMD1B; the disease is Ito hypomelanosis.